Press Releases

PRINCETON, N.J., Oct. 24, 2019 /PRNewswire/ -- Three hospital associations in New Jersey, Ohio and Pennsylvania today announced the creation of Q3 Health Innovation Partners (Q3HIP), a new joint venture to improve health quality and patient safety.Q3HIP is compr

NEW YORK, Oct. 24, 2019 /PRNewswire/ --

FORT WORTH, Texas, Oct. 24, 2019 /PRNewswire/ -- Galderma, maker of

NEW YORK, Oct. 24, 2019 /PRNewswire/ -- According to the Centers for Disease Control and Prevention (CDC), the flu virus can spread to others up to six feet away.

FLORENCE, Italy, Oct. 24, 2019 /PRNewswire/ -- His discoveries have changed the lives of millions of people. Thanks to his insight, he has won the world's most prestigious scientific honour. Today, his valuable experience will contribute towards bolstering the mission of the "Fondazione Internazionale Menarini" which welcomes the winner of the Nobel prize for Medicine,

TAMPA, Fla., Oct. 24, 2019 /PRNewswire/ -- The Boys & Girls Clubs of the Suncoast recently recognized Ultimate Medical Academy (UMA) for the institution's long-standing and continuing support of the organization and its goal to save and change the lives of children and teens.

OSLO, Norway, Oct. 24, 2019 /PRNewswire/ -- Tone Kvåle, CFO, has today, 24 October 2019, purchased 5,000 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 19.96 per share. Following this transaction, Tone Kvåle holds 45,000 PSUs, 315,000 options and 191,275 shares in th

NEW YORK, Oct. 24, 2019 /PRNewswire/ -- The New York Genome Center (NYGC) is pleased to announce the appointment of Thomas Lehner, PhD, MPH, as its Scientific Director of Neuropsychiatric Disease Genomics. A highly regarded expert in neuropsychiatric genomics, Dr. Lehner will join the NYGC on January 6, 2020

NEW YORK, Oct. 24, 2019 /PRNewswire/ -- The Lupus Research Alliance proudly announces two exceptional recipients of the 2019 Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity: Fabienne Mackay, PhD, and Jeffrey Rathmell, PhD. The highly prestigious up-to-

SILVER SPRING, Md., Oct. 24, 2019 /PRNewswire/ -- Addressing the opioid crisis continues to be one of the FDA's top public health priorities. While it is encouraging to see that, according to provisional data, total drug overdose deaths in the United States dropped 5.1% from 2017 to 2018 – the first decrease in more than two decades – we still have much work to do as deaths from drug overdoses remain at historically high